Frontiers SARS-CoV-2 Spike Protein Expression In Vitro and

Severe COVID-19 can be associated with a prothrombotic state, increasing risk of morbidity and mortality. The SARS-CoV-2 spike glycoprotein is purported to d

Frontiers Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza

Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples - ScienceDirect

Frontiers Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19

Frontiers Ectopic expression of SARS-CoV-2 S and ORF-9B proteins

Viruses: What triggers inflammation in COVID-19?

SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19

Frontiers Development of Plant-Produced Recombinant ACE2-Fc

An integrative look at SARS‑CoV‑2 (Review)

Frontiers SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation

Frontiers ACE2 Shedding and the Role in COVID-19